Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Treatment of melanoma-patient-derived TAFs with IL-1?/? significantly enhanced their ability to suppress the proliferation and function of melanoma-specific cytotoxic T cells, and this inhibition was partially attributable to upregulation by IL-1 of COX-2 and the PD-1 ligands PD-L1 and PD-L2 in TAFs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP547148.RAShcPTsisSSra2-EtAtFfk739BSfUn6O2cAlkOLEF8M8130_assertion description "[Treatment of melanoma-patient-derived TAFs with IL-1?/? significantly enhanced their ability to suppress the proliferation and function of melanoma-specific cytotoxic T cells, and this inhibition was partially attributable to upregulation by IL-1 of COX-2 and the PD-1 ligands PD-L1 and PD-L2 in TAFs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547148.RAShcPTsisSSra2-EtAtFfk739BSfUn6O2cAlkOLEF8M8130_provenance.
• NP363087.RA0E_fYUwWSSCGS83MFEJ3DfKXNQg0eIrcdxy-a2A89wQ130_assertion description "[Treatment of melanoma-patient-derived TAFs with IL-1?/? significantly enhanced their ability to suppress the proliferation and function of melanoma-specific cytotoxic T cells, and this inhibition was partially attributable to upregulation by IL-1 of COX-2 and the PD-1 ligands PD-L1 and PD-L2 in TAFs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP363087.RA0E_fYUwWSSCGS83MFEJ3DfKXNQg0eIrcdxy-a2A89wQ130_provenance.
• NP302574.RAp05kBFYLCt_zi6bIyVbdJ5yduXMtOWbbcn1nEskXJ0o130_assertion description "[Treatment of melanoma-patient-derived TAFs with IL-1?/? significantly enhanced their ability to suppress the proliferation and function of melanoma-specific cytotoxic T cells, and this inhibition was partially attributable to upregulation by IL-1 of COX-2 and the PD-1 ligands PD-L1 and PD-L2 in TAFs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP302574.RAp05kBFYLCt_zi6bIyVbdJ5yduXMtOWbbcn1nEskXJ0o130_provenance.
• NP692810.RAp47Lqk8QT4AXejKZnzL_E_Ei49B7rT-nXfFH_Q7wchE130_assertion description "[Treatment of melanoma-patient-derived TAFs with IL-1?/? significantly enhanced their ability to suppress the proliferation and function of melanoma-specific cytotoxic T cells, and this inhibition was partially attributable to upregulation by IL-1 of COX-2 and the PD-1 ligands PD-L1 and PD-L2 in TAFs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP692810.RAp47Lqk8QT4AXejKZnzL_E_Ei49B7rT-nXfFH_Q7wchE130_provenance.
• NP728128.RAtdGLP71KOvJrHuhPtJB7ZQKggdHse9RI0OObkPePYqc130_assertion description "[Treatment of melanoma-patient-derived TAFs with IL-1?/? significantly enhanced their ability to suppress the proliferation and function of melanoma-specific cytotoxic T cells, and this inhibition was partially attributable to upregulation by IL-1 of COX-2 and the PD-1 ligands PD-L1 and PD-L2 in TAFs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP728128.RAtdGLP71KOvJrHuhPtJB7ZQKggdHse9RI0OObkPePYqc130_provenance.
• NP401048.RAKc4orOx6DzibEiwcaRWVw8hPhDA9tNx006Hi12BV8iY130_assertion description "[Treatment of melanoma-patient-derived TAFs with IL-1?/? significantly enhanced their ability to suppress the proliferation and function of melanoma-specific cytotoxic T cells, and this inhibition was partially attributable to upregulation by IL-1 of COX-2 and the PD-1 ligands PD-L1 and PD-L2 in TAFs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP401048.RAKc4orOx6DzibEiwcaRWVw8hPhDA9tNx006Hi12BV8iY130_provenance.
• NP506591.RAy1nQxUK-tqekaM1rffWor-8fQzbTegpzARx46d3dPO0130_assertion description "[Treatment of melanoma-patient-derived TAFs with IL-1?/? significantly enhanced their ability to suppress the proliferation and function of melanoma-specific cytotoxic T cells, and this inhibition was partially attributable to upregulation by IL-1 of COX-2 and the PD-1 ligands PD-L1 and PD-L2 in TAFs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP506591.RAy1nQxUK-tqekaM1rffWor-8fQzbTegpzARx46d3dPO0130_provenance.
• NP489468.RAQpxMAe4WfXKu3B23aQbyr5mPfSZ5t2XSLKM-jeI4aOI130_assertion description "[Treatment of melanoma-patient-derived TAFs with IL-1?/? significantly enhanced their ability to suppress the proliferation and function of melanoma-specific cytotoxic T cells, and this inhibition was partially attributable to upregulation by IL-1 of COX-2 and the PD-1 ligands PD-L1 and PD-L2 in TAFs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP489468.RAQpxMAe4WfXKu3B23aQbyr5mPfSZ5t2XSLKM-jeI4aOI130_provenance.
• NP534392.RAJX4nJN-oWe00Hb0zlwhfHQc_EDnC5OFJZifm38lVdqM130_assertion description "[Treatment of melanoma-patient-derived TAFs with IL-1?/? significantly enhanced their ability to suppress the proliferation and function of melanoma-specific cytotoxic T cells, and this inhibition was partially attributable to upregulation by IL-1 of COX-2 and the PD-1 ligands PD-L1 and PD-L2 in TAFs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP534392.RAJX4nJN-oWe00Hb0zlwhfHQc_EDnC5OFJZifm38lVdqM130_provenance.
• NP539859.RAL3-CN2FTecBqXiWUHUfyRqAWqPB7Jbi1dtTaOSKoz9E130_assertion description "[Treatment of melanoma-patient-derived TAFs with IL-1?/? significantly enhanced their ability to suppress the proliferation and function of melanoma-specific cytotoxic T cells, and this inhibition was partially attributable to upregulation by IL-1 of COX-2 and the PD-1 ligands PD-L1 and PD-L2 in TAFs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP539859.RAL3-CN2FTecBqXiWUHUfyRqAWqPB7Jbi1dtTaOSKoz9E130_provenance.
• assertion description "[Treatment of melanoma-patient-derived TAFs with IL-1?/? significantly enhanced their ability to suppress the proliferation and function of melanoma-specific cytotoxic T cells, and this inhibition was partially attributable to upregulation by IL-1 of COX-2 and the PD-1 ligands PD-L1 and PD-L2 in TAFs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Treatment of melanoma-patient-derived TAFs with IL-1?/? significantly enhanced their ability to suppress the proliferation and function of melanoma-specific cytotoxic T cells, and this inhibition was partially attributable to upregulation by IL-1 of COX-2 and the PD-1 ligands PD-L1 and PD-L2 in TAFs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Treatment of melanoma-patient-derived TAFs with IL-1?/? significantly enhanced their ability to suppress the proliferation and function of melanoma-specific cytotoxic T cells, and this inhibition was partially attributable to upregulation by IL-1 of COX-2 and the PD-1 ligands PD-L1 and PD-L2 in TAFs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP657375.RAiF6yzxhTuPcj32FI3BQMZqQxV-0kkDunKavLjyXFHwM130_assertion description "[Treatment of melanoma-patient-derived TAFs with IL-1?/? significantly enhanced their ability to suppress the proliferation and function of melanoma-specific cytotoxic T cells, and this inhibition was partially attributable to upregulation by IL-1 of COX-2 and the PD-1 ligands PD-L1 and PD-L2 in TAFs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP657375.RAiF6yzxhTuPcj32FI3BQMZqQxV-0kkDunKavLjyXFHwM130_provenance.
• NP949562.RAp8iRIGjGpRZp2CTBVcVe536pV9yCSOEaIGrGNJV9fHc130_assertion description "[Treatment of melanoma-patient-derived TAFs with IL-1?/? significantly enhanced their ability to suppress the proliferation and function of melanoma-specific cytotoxic T cells, and this inhibition was partially attributable to upregulation by IL-1 of COX-2 and the PD-1 ligands PD-L1 and PD-L2 in TAFs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP949562.RAp8iRIGjGpRZp2CTBVcVe536pV9yCSOEaIGrGNJV9fHc130_provenance.
• NP1001886.RACR3okH4b0bb_oUIqBU-YQanMCOZMUQNpFpq5KYT-GCw130_assertion description "[Treatment of melanoma-patient-derived TAFs with IL-1?/? significantly enhanced their ability to suppress the proliferation and function of melanoma-specific cytotoxic T cells, and this inhibition was partially attributable to upregulation by IL-1 of COX-2 and the PD-1 ligands PD-L1 and PD-L2 in TAFs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1001886.RACR3okH4b0bb_oUIqBU-YQanMCOZMUQNpFpq5KYT-GCw130_provenance.
• NP893868.RAiIf4huYIIU-qpwvrRq86bw4Yqm47N74aWtshDAc1Sdk130_assertion description "[Treatment of melanoma-patient-derived TAFs with IL-1?/? significantly enhanced their ability to suppress the proliferation and function of melanoma-specific cytotoxic T cells, and this inhibition was partially attributable to upregulation by IL-1 of COX-2 and the PD-1 ligands PD-L1 and PD-L2 in TAFs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP893868.RAiIf4huYIIU-qpwvrRq86bw4Yqm47N74aWtshDAc1Sdk130_provenance.
• NP1001893.RAkW0sipH4GI2lEpCJ91QFr32v-FNMip2g9V8WBVBdw8s130_assertion description "[Treatment of melanoma-patient-derived TAFs with IL-1?/? significantly enhanced their ability to suppress the proliferation and function of melanoma-specific cytotoxic T cells, and this inhibition was partially attributable to upregulation by IL-1 of COX-2 and the PD-1 ligands PD-L1 and PD-L2 in TAFs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1001893.RAkW0sipH4GI2lEpCJ91QFr32v-FNMip2g9V8WBVBdw8s130_provenance.
• NP573275.RAIG-AjyBKwGOBvJh4Uv6vNLnLk-a7gMIKzNmSk8Z0xL8130_assertion description "[Treatment of melanoma-patient-derived TAFs with IL-1?/? significantly enhanced their ability to suppress the proliferation and function of melanoma-specific cytotoxic T cells, and this inhibition was partially attributable to upregulation by IL-1 of COX-2 and the PD-1 ligands PD-L1 and PD-L2 in TAFs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP573275.RAIG-AjyBKwGOBvJh4Uv6vNLnLk-a7gMIKzNmSk8Z0xL8130_provenance.
• NP487766.RAHzrRKEVIt0DlXJrExFF8-5nuMA1iAZSg6lUD_o0nC80130_assertion description "[Treatment of melanoma-patient-derived TAFs with IL-1?/? significantly enhanced their ability to suppress the proliferation and function of melanoma-specific cytotoxic T cells, and this inhibition was partially attributable to upregulation by IL-1 of COX-2 and the PD-1 ligands PD-L1 and PD-L2 in TAFs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP487766.RAHzrRKEVIt0DlXJrExFF8-5nuMA1iAZSg6lUD_o0nC80130_provenance.
• NP1001884.RAJGBiXotANVAYsC3RolPt6NlFc05vZV__Yyka4Ufz978130_assertion description "[Treatment of melanoma-patient-derived TAFs with IL-1?/? significantly enhanced their ability to suppress the proliferation and function of melanoma-specific cytotoxic T cells, and this inhibition was partially attributable to upregulation by IL-1 of COX-2 and the PD-1 ligands PD-L1 and PD-L2 in TAFs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1001884.RAJGBiXotANVAYsC3RolPt6NlFc05vZV__Yyka4Ufz978130_provenance.
• NP1001888.RAFWteVelGIz73HEFAL87QGpAXgSTrCxfhzwrEw46tnYo130_assertion description "[Treatment of melanoma-patient-derived TAFs with IL-1?/? significantly enhanced their ability to suppress the proliferation and function of melanoma-specific cytotoxic T cells, and this inhibition was partially attributable to upregulation by IL-1 of COX-2 and the PD-1 ligands PD-L1 and PD-L2 in TAFs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1001888.RAFWteVelGIz73HEFAL87QGpAXgSTrCxfhzwrEw46tnYo130_provenance.
• NP1001891.RAPWDKpOQj6o41GVj88IgD3rCTr1ytCMs3I2swz2nGpIU130_assertion description "[Treatment of melanoma-patient-derived TAFs with IL-1?/? significantly enhanced their ability to suppress the proliferation and function of melanoma-specific cytotoxic T cells, and this inhibition was partially attributable to upregulation by IL-1 of COX-2 and the PD-1 ligands PD-L1 and PD-L2 in TAFs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1001891.RAPWDKpOQj6o41GVj88IgD3rCTr1ytCMs3I2swz2nGpIU130_provenance.
• NP1001890.RA_GbchH-VN_UVo3fO-kC0wmarYJ68q8qoeEGhBQLEsxg130_assertion description "[Treatment of melanoma-patient-derived TAFs with IL-1?/? significantly enhanced their ability to suppress the proliferation and function of melanoma-specific cytotoxic T cells, and this inhibition was partially attributable to upregulation by IL-1 of COX-2 and the PD-1 ligands PD-L1 and PD-L2 in TAFs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1001890.RA_GbchH-VN_UVo3fO-kC0wmarYJ68q8qoeEGhBQLEsxg130_provenance.